Abiopharma

New Form 425 - Alcoa Corp <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0000950103-26-009900 <b>Size:</b> 2 MB

New Form 3 - MIZUHO FINANCIAL GROUP INC <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001193125-26-291434 <b>Size:</b> 14 KB

New Form 424B5 - Biodexa Pharmaceuticals Plc <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001214659-26-007998 <b>Size:</b> 202 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001213900-26-073955 <b>Size:</b> 2 MB

New Form 424B7 - DIGITAL REALTY TRUST, INC. <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001193125-26-291397 <b>Size:</b> 945 KB

New Form PRE 14A - VisionWave Holdings, Inc. <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001731122-26-000903 <b>Size:</b> 529 KB

New Form 424B5 - Curbline Properties Corp. <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001193125-26-291411 <b>Size:</b> 885 KB

New Form EFFECT - FIREFLY NEUROSCIENCE, INC. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 9999999995-26-002161 <b>Size:</b> 1 KB

New Form EFFECT - T3 Defense Inc. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 9999999995-26-002164 <b>Size:</b> 1 KB

Warrants - Outstanding Position Reporting: SGX DLC Quarterly Report Q2 2026